Cycloferon tablets p / o enteric 150mg №10×5

Name:
Cycloferon tab. to/r. about. 150mg per cont. cell pack. No. 10×5
Description:
Round biconvex yellow tablets, enteric-coated. The main active ingredient Meglumine acridon acetate Release form tablets Dosage 150 mg Pharmacological properties Pharmacodynamics Cycloferon is a low molecular weight interferon inducer, which determines a wide range of its biological activity (antiviral, immunomodulatory, anti-inflammatory, etc.). The antiviral effect of Cycloferon against herpes viruses, influenza and other pathogens of acute respiratory diseases has been demonstrated in vitro and in animal models. The use of an infectious process in the early stages (1-5 days) helps to reduce the infectivity of viral progeny, the formation of defective viral particles. Increases nonspecific resistance against viral and bacterial infections. Pharmacokinetics When taking a daily dose, the maximum concentration in blood plasma is reached after 2-3 hours, gradually decreases by the 8th hour, and after 24 hours Cycloferon is found in trace amounts. The half-life of the drug is 4-5 hours, so its use in recommended doses does not create conditions for cumulation in the body. Excreted by the kidneys unchanged. Indications for use In adults in complex therapy: influenza and acute respiratory diseases; herpetic infection. In children from four years of age in complex therapy: influenza and acute respiratory diseases; herpetic infection. In children from the age of four, for the prevention of influenza and acute respiratory diseases. Dosage and administration Inside once a day 30 minutes before meals, without chewing, drinking ? a glass of water, in age dosages: children 4-6 years old: 150 mg (1 tablet) per dose; children 7-11 years old: 300-450 mg (2-3 tablets) per dose; adults and children over 12 years old: 450-600 mg (3-4 tablets) per dose. It is advisable to repeat the course 2-3 weeks after the end of the first course. In adults: In the treatment of influenza and acute respiratory diseases, the drug is taken on the 1st, 2nd, 4th, 6th, 8th day (course of treatment – 20 tablets). Treatment should be started at the first symptoms of the disease. In severe cases of influenza, six tablets are taken on the first day. If necessary, symptomatic therapy is additionally carried out (antipyretic, analgesic, expectorant drugs). In case of herpetic infection, the drug is taken on the 1st, 2nd, 4th, 6th, 8th, 11th, 14th, 17th, 20th, 23rd days (treatment course – 40 tablets). Treatment is most effective when the first symptoms of the disease appear. In children from four years of age: In case of influenza and acute respiratory diseases, the drug is taken in age doses on the 1st, 2nd, 4th, 6th, 8th, 11th, 14th, 17th, 20th, 23rd days. The course of treatment is from 5 to 10 doses, depending on the severity of the condition and the severity of clinical symptoms. In case of herpetic infection, the drug is taken on the 1st, 2nd, 4th, 6th, 8th, 11th, 14th days of treatment. The course of treatment may vary depending on the severity of the condition and the severity of clinical symptoms. For emergency non-specific prophylaxis of influenza and acute respiratory diseases (with direct contact with patients with influenza or acute respiratory infections of other etiologies, during an influenza epidemic), the drug is taken on the 1st, 2nd, 4th, 6th, 8th day. Next, a break of 72 hours (three days) is carried out and the course is continued for 11, 14, 17, 20, 23 days. The general course is from 5 to 10 receptions. Tactics of the patient when skipping the next dose of the drug If the next dose of the drug is missed, then you should take the missed dose as soon as possible and then continue the course according to the started scheme. Use in elderly patients No change in dosing regimen is required. Use in patients with impaired renal function No change in dosing regimen is required. Use in patients with impaired liver function No change in dosing regimen is required. Precautions In case of diseases of the digestive system in the acute stage (erosion, stomach and / or duodenal ulcers, gastritis and duodenitis) and a history of allergic reactions, be sure to consult your doctor before taking the drug. In case of thyroid diseases, consultation of an endocrinologist is necessary. Influence on the ability to drive vehicles and mechanisms Does not affect the ability to drive vehicles and mechanisms. In the absence of a therapeutic effect, you should consult a doctor. Interaction with other drugs Cycloferon is compatible with all drugs used in the treatment of these diseases (interferons, chemotherapeutic, symptomatic drugs, etc.). Enhances the action of interferons and nucleoside analogues. Reduces the side effects of chemotherapy, interferon therapy. Contraindications Pregnancy, breastfeeding, children under 4 years of age (due to imperfect swallowing), individual intolerance to the components of the drug, decompensated liver cirrhosis. Composition Per tablet: active substance: meglumine acridone acetate in terms of acridoneacetic acid 150 mg, obtained according to the following prescription: acridoneacetic acid 150 mg, N-methylglucamine (meglumine) 146 mg; excipients: povidone K 30, calcium stearate, hypromellose 2910 (6 cp), polysorbate 80, methacrylic acid and ethyl acrylate copolymer (1:1), propylene glycol. Overdose To date, cases of drug overdose have not been established. Side effectsAccording to the World Health Organization, undesirable effects are classified according to their frequency of development as follows: very frequent (? 1/10); frequent (?1/100 – <1/10); infrequent (?1/1000 - <1/100); rare (?1/10000 - <1/1000); very rare (<1/10000); frequency unknown (frequency cannot be determined from available data). Immune system disorders: very rarely - angioedema. Skin and subcutaneous tissue disorders: very rarely - rash, urticaria. If the listed adverse reactions occur, as well as a reaction not indicated in the instructions for use, you should contact your doctor. Storage conditions In a place protected from light at a temperature not exceeding 25 ° C. Keep out of the reach of children. Buy Cycloferon tablets p/o enteric 150mg №10x5 Price for Cycloferon tablets p/o enteric 150mg №10x5